Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

A United Kingdom Perspective on the Appropriateness of Percutaneous Coronary Intervention in Stable Angina

Presenter: Benjamin Wrigley, Nikesh Malik, Amerjeet Banning, Raj Rajendra, Gail Richardson, Anthony Gershlick

January 31, 2013

Presentation

Mini-COREA: Celecoxib, una Espada de Doble Filo para Pacientes con Angina

Presenter: H. J. Kang

March 14, 2012

Presentation

Mini-COREA: Celecoxib, a Double-edged Sword for Patients with Angina

Presenter: H.J. Kang

March 14, 2012

Presentation TCT 2012

Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina

Presenter: Hiromasa Otake, Junya Shite, Toshiro Shinke, Ken-ichi Hirata

January 03, 2012

Advertisement

Absorb III/IV: Angina and Ischemia Hypotheses

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

A United Kingdom Perspective on the Appropriateness of Percutaneous Coronary Intervention in Stable Angina

Mini-COREA: Celecoxib, una Espada de Doble Filo para Pacientes con Angina

Mini-COREA: Celecoxib, a Double-edged Sword for Patients with Angina

Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content